Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares traded.
Liberty Biopharma Price Performance
The stock has a market cap of C$21.54 million and a P/E ratio of -12.66. The firm has a 50-day moving average price of C$2.00 and a 200-day moving average price of C$2.00. The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12.
About Liberty Biopharma
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Stories
- Five stocks we like better than Liberty Biopharma
- Do ETFs Pay Dividends? What You Need to Know
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Options Trading – Understanding Strike Price
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- What Do S&P 500 Stocks Tell Investors About the Market?
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
